pk 11195 and u 0126
pk 11195 has been researched along with u 0126 in 4 studies
Research
Studies (4)
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 3 (75.00) | 29.6817 |
| 2010's | 1 (25.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
Authors
| Authors | Studies |
|---|---|
| Bellows, DS; Clarke, ID; Diamandis, P; Dirks, PB; Graham, J; Jamieson, LG; Ling, EK; Sacher, AG; Tyers, M; Ward, RJ; Wildenhain, J | 1 |
| Austin, CP; Fidock, DA; Hayton, K; Huang, R; Inglese, J; Jiang, H; Johnson, RL; Su, XZ; Wellems, TE; Wichterman, J; Yuan, J | 1 |
| Venneti, S; Wang, G; Wiley, CA | 1 |
| Gyrylova, SN; Komina, AV; Ruksha, TG | 1 |
Other Studies
4 other study(ies) available for pk 11195 and u 0126
| Article | Year |
|---|---|
Chemical genetics reveals a complex functional ground state of neural stem cells.
Topics: Animals; Cell Survival; Cells, Cultured; Mice; Molecular Structure; Neoplasms; Neurons; Pharmaceutical Preparations; Sensitivity and Specificity; Stem Cells | 2007 |
Genetic mapping of targets mediating differential chemical phenotypes in Plasmodium falciparum.
Topics: Animals; Antimalarials; ATP Binding Cassette Transporter, Subfamily B, Member 1; Chromosome Mapping; Crosses, Genetic; Dihydroergotamine; Drug Design; Drug Resistance; Humans; Inhibitory Concentration 50; Mutation; Plasmodium falciparum; Quantitative Trait Loci; Transfection | 2009 |
Activated macrophages in HIV encephalitis and a macaque model show increased [3H](R)-PK11195 binding in a PI3-kinase-dependent manner.
Topics: Analysis of Variance; Animals; Antineoplastic Agents; Autoradiography; Binding, Competitive; Butadienes; Chromones; Disease Models, Animal; Dose-Response Relationship, Drug; Encephalitis; Enzyme Inhibitors; HIV; Isoquinolines; Lipopolysaccharides; Macaca; Macrophage Activation; Morpholines; Nitriles; Phosphatidylinositol 3-Kinases; Positron-Emission Tomography; Simian Immunodeficiency Virus; Tritium | 2007 |
[TSPO ligand PK11195 and MAPK inhibitor UO126 modulate tspo expression level].
Topics: Butadienes; Cell Line, Tumor; Gene Expression Regulation, Neoplastic; Humans; Isoquinolines; MAP Kinase Signaling System; Melanoma; Mitogen-Activated Protein Kinase Kinases; Nitriles; Receptors, GABA | 2013 |